Krishnamurthi S, Shanta V, Shastri D V, Sharma M
Strahlentherapie. 1984 Nov;160(11):684-7.
Two-thirds of all cancers in South India are squamous cell carcinomas, of which 78% to 93% are late cases requiring radiotherapy. Oral cancers, which constitute the majority of these, provided an excellent clinical model for studies in radiotherapeutic biology. Their characteristics made them ideally suited for our clinical trials. The paper reviews the special biology of these lesions, the factors involved in their radiation non-response, the therapeutic postulations that suggested themselves, the implementation of these therapeutic protocols and the mixed story of failure and success that has marked the two decades of these studies. It discovers the fact that radiation response is not just a factor of tumor extent but involves several biological subtleties in both tumor and its host environment. It also discusses possible future approaches to bridge a gap of about 30% failure in these lesions, especially in the context of a poor economy.
印度南部三分之二的癌症为鳞状细胞癌,其中78%至93%为晚期病例,需要进行放射治疗。口腔癌占这些病例的大多数,为放射治疗生物学研究提供了一个极佳的临床模型。其特征使其非常适合我们的临床试验。本文回顾了这些病变的特殊生物学特性、其放射抗拒所涉及的因素、由此提出的治疗假设、这些治疗方案的实施情况,以及标志着这二十年研究的成败交织的情况。研究发现,放射反应不仅仅是肿瘤范围的一个因素,还涉及肿瘤及其宿主环境中的几个生物学微妙之处。本文还讨论了未来可能采取的方法,以弥补这些病变中约30%的治疗失败率,尤其是在经济状况不佳的背景下。